Quantcast

Latest Diabetes management Stories

smartphone diabetes control
2014-06-15 06:15:40

redOrbit Staff & Wire Reports - Your Universe Online Researchers from the Scripps Whittier Diabetes Institute have devised a new text message program which they claim could help patients control their diabetes by sending them information about proper nutritional habits, the benefits of physical activities and reminders to check blood sugar on a regular basis. The program is part of the Dulce Digital study, and initial results suggest a text message-based self-management intervention...

2014-06-14 12:21:12

Results from Clinical Study in Type 2 Diabetes Patients with Renal Impairment and Preclinical Study in Type 1 Diabetes THE WOODLANDS, Texas, June 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), presented data at the 74(th) Scientific Sessions of the American Diabetes Association (ADA) in San Francisco on LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) that is designed to lower blood glucose levels through...

2014-06-14 12:21:08

PARIS, June 14, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia(®) (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study versus liraglutide, showing a significantly more pronounced post-prandial (after-meal) glucose (blood sugar) lowering effect after a test-meal than liraglutide when both were added to optimally titrated Lantus(®) (insulin glargine). Lowering of post-prandial glucose was measured as change...

2014-06-14 12:20:58

During the 1-year program, patients showed statistically significant reductions in blood glucose levels, increased belief in their ability to self-manage their diabetes and improved perceptions of support, while the community showed statistically significant increases in diabetes awareness SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- The American Academy of Family Physicians Foundation announced today that the Cities for Life program, supported by Sanofi US, helped decrease blood glucose...

2014-06-14 12:20:45

Once-Weekly Dulaglutide 1.5 mg Also Demonstrates Weight Loss, Low Rates of Hypoglycemia in AWARD-6 Trial SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today released detailed results from dulaglutide's sixth AWARD trial, showing that once-weekly dulaglutide 1.5 mg was non-inferior to once-daily liraglutide 1.8 mg. The non-inferiority study demonstrated similar reductions in average blood sugar levels (HbA1c) across both arms.(1) The head-to-head study compared...

2014-06-14 12:20:40

Companies present comprehensive data for LY2963016, investigational new insulin glargine product SAN FRANCISCO, June 14, 2014 /PRNewswire/ -- For the first time today, Eli Lilly and Company (NYSE:LLY) and Boehringer Ingelheim Pharmaceuticals Inc. presented data showing that LY2963016, the alliance's investigational new insulin glargine product, has a similar safety and efficacy profile to currently marketed insulin glargine (Lantus(®)).(1,2,3,4,5,6) Results from these Phase I and Phase III...

2014-06-12 08:30:22

Announces Simple Savings Program to Make Test Strip Replacement Convenient and Affordable, Essentially Eliminating the Need for Insurance Reimbursement MOUNTAIN VIEW, Calif., June 12, 2014 /PRNewswire/ -- Today, iHealth Lab Inc. announced the launch of the iHealth Align, the world's smallest, FDA-approved mobile blood glucose monitor. The meter plugs directly into a smart phone and displays and stores readings using the iHealth Gluco-Smart app. By displaying readings directly on the...

2014-06-10 20:23:10

ROCKVILLE, Md., June 10, 2014 /PRNewswire-USNewswire/ -- Patients with type 2 diabetes who take a combination of metformin plus insulin may be at higher risk for cardiovascular disease and death compared with those who take a combination of metformin plus sulfonylurea, according to a new study funded by the Agency for Healthcare Research and Quality (AHRQ) that appears in the June 11 issue of JAMA. The study, a review of medical records from national databases, found a greater...

2014-06-10 08:30:52

Phase 3 Study Results Across Different Patient Populations, Including Comparative Analyses with Sitagliptin and Health Economics Data, are Among 15 Accepted Presentations RARITAN, N.J., June 10, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that 15 presentations on INVOKANA(®) (canagliflozin) will be made at the American Diabetes Association (ADA) 74(th) Scientific Sessions(®), June 13-17 in San Francisco. The presentations include long-term safety...

Sharp Uptick In Pre-Diabetes Observed In England
2014-06-10 09:14:12

Brett Smith for redOrbit.com - Your Universe Online While diabetes has been a major public health threat in the US for some time, a new report published in the journal BMJ Open has found that rates of pre-diabetes in England have risen sharply. This means that without significant interventions, the country could see a spike in diabetes within the coming years. “The rapid rise was exceptionally surprising and suggests that if something doesn’t happen, there is going to be a huge...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related